Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Moschetta

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Critical Reviews in Oncology/Hematology|December 31, 2020
Melanoma of unknown primary: New perspectives for an old storyStergios Boussios, Elie Rassy, Eleftherios Samartzis, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 12, 2020
Langerhans cell histiocytosis with spinal, pulmonary and pituitary involvement: What about ACTH deficiency without diabetes insipidus? A propos of a caseJake E Ryan, Vijayakumar Ganesh, Afroditi Karathanasi, et al.
Proteomes|June 1, 2022
Applications of Proteomics in Ovarian Cancer: Dawn of a New EraAruni Ghose, Sri Vidya Niharika Gullapalli, Naila Chohan, et al.
Biomed Research International|January 11, 2018
Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 BlockadeMichele Moschetta, Mario Uccello, Benjamin Kasenda, et al.
Current Cancer Drug Targets|February 9, 2023
Advances in Ovarian Cancer Treatment Beyond PARP InhibitorsFine Aliyuda, Michele Moschetta, Aruni Ghose, et al.
Diagnostics (Basel, Switzerland)|May 22, 2019
PARP Inhibitors in Ovarian Cancer: The Route to "Ithaca"Stergios Boussios, Afroditi Karathanasi, Deirdre Cooke, et al.
Stem Cells International|June 16, 2012
Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myelomaRoberto Ria, Antonia Reale, Antonio Giovanni Solimando, et al.
Annals of Palliative Medicine|July 11, 2023
Melanoma-the therapeutic considerations in the clinical practiceSola Adeleke, Somto Okoli, Anojan Augustine, et al.
Biochimica Et Biophysica Acta|April 9, 2014
Role of endothelial progenitor cells in cancer progressionMichele Moschetta, Yuji Mishima, Ilyas Sahin, et al.
Drugs in R&D|March 28, 2020
Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and BeyondStergios Boussios, Charlotte Abson, Michele Moschetta, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Critical Reviews in Oncology/Hematology|December 31, 2020
Melanoma of unknown primary: New perspectives for an old storyStergios Boussios, Elie Rassy, Eleftherios Samartzis, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 12, 2020
Langerhans cell histiocytosis with spinal, pulmonary and pituitary involvement: What about ACTH deficiency without diabetes insipidus? A propos of a caseJake E Ryan, Vijayakumar Ganesh, Afroditi Karathanasi, et al.
Proteomes|June 1, 2022
Applications of Proteomics in Ovarian Cancer: Dawn of a New EraAruni Ghose, Sri Vidya Niharika Gullapalli, Naila Chohan, et al.
Biomed Research International|January 11, 2018
Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 BlockadeMichele Moschetta, Mario Uccello, Benjamin Kasenda, et al.
Current Cancer Drug Targets|February 9, 2023
Advances in Ovarian Cancer Treatment Beyond PARP InhibitorsFine Aliyuda, Michele Moschetta, Aruni Ghose, et al.
Diagnostics (Basel, Switzerland)|May 22, 2019
PARP Inhibitors in Ovarian Cancer: The Route to "Ithaca"Stergios Boussios, Afroditi Karathanasi, Deirdre Cooke, et al.
Stem Cells International|June 16, 2012
Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myelomaRoberto Ria, Antonia Reale, Antonio Giovanni Solimando, et al.
Annals of Palliative Medicine|July 11, 2023
Melanoma-the therapeutic considerations in the clinical practiceSola Adeleke, Somto Okoli, Anojan Augustine, et al.
Biochimica Et Biophysica Acta|April 9, 2014
Role of endothelial progenitor cells in cancer progressionMichele Moschetta, Yuji Mishima, Ilyas Sahin, et al.
Drugs in R&D|March 28, 2020
Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and BeyondStergios Boussios, Charlotte Abson, Michele Moschetta, et al.
Pageof 9